- Home
- MYFW vs AARD Comparison
MYFW vs AARD Comparison
Compare MYFW & AARD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYFW
- AARD
- Stock Information
- Founded
- MYFW 2002
- AARD 2017
- Country
- MYFW United States
- AARD United States
- Employees
- MYFW N/A
- AARD N/A
- Industry
- MYFW Major Banks
- AARD Biotechnology: Pharmaceutical Preparations
- Sector
- MYFW Finance
- AARD Health Care
- Exchange
- MYFW Nasdaq
- AARD Nasdaq
- Market Cap
- MYFW 201.1M
- AARD 186.3M
- IPO Year
- MYFW 2018
- AARD 2025
- Fundamental
- Price
- MYFW $22.59
- AARD $10.32
- Analyst Decision
- MYFW Buy
- AARD Strong Buy
- Analyst Count
- MYFW 2
- AARD 5
- Target Price
- MYFW $24.25
- AARD $32.60
- AVG Volume (30 Days)
- MYFW 23.5K
- AARD 182.3K
- Earning Date
- MYFW 10-23-2025
- AARD 11-14-2025
- Dividend Yield
- MYFW N/A
- AARD N/A
- EPS Growth
- MYFW 226.95
- AARD N/A
- EPS
- MYFW 1.18
- AARD N/A
- Revenue
- MYFW $93,514,000.00
- AARD N/A
- Revenue This Year
- MYFW $14.41
- AARD N/A
- Revenue Next Year
- MYFW $12.25
- AARD N/A
- P/E Ratio
- MYFW $19.68
- AARD N/A
- Revenue Growth
- MYFW 16.68
- AARD N/A
- 52 Week Low
- MYFW $17.10
- AARD $4.88
- 52 Week High
- MYFW $24.88
- AARD $19.58
- Technical
- Relative Strength Index (RSI)
- MYFW 51.53
- AARD N/A
- Support Level
- MYFW N/A
- AARD N/A
- Resistance Level
- MYFW $23.74
- AARD N/A
- Average True Range (ATR)
- MYFW 0.56
- AARD 0.00
- MACD
- MYFW -0.85
- AARD 0.00
- Stochastic Oscillator
- MYFW 95.16
- AARD 0.00
About MYFW First Western Financial Inc.
First Western Financial Inc is a financial holding company that provides a fully integrated suite of wealth management services on its private trust bank platform, which includes a comprehensive selection of deposit, loan, trust, wealth planning, and investment management products and services. The company has two operating segments; The Wealth Management segment consists of operations relative to the Company's fully integrated wealth management products and services, and The Mortgage segment consists of operations relative to the Company's residential mortgage service offerings. The bank derives its majority revenue from the wealth management segment.
About AARD Aardvark Therapeutics Inc. Common Stock
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.